WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 5 fonti

Bristol-Myers Squibb deploys Anthropic Claude to 30,000 employees

The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs

Raccontata dabiopharmadive.comqz.comfiercepharma.comcryptobriefing.compharmaceutical-technology.com

Confronto fonti

5 prospettive sulla stessa storia
AI · summaries
qz.comStai leggendo1 mesi fa

Bristol-Myers Squibb deploys Anthropic Claude to 30,000 employees

The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs

originale
cryptobriefing.com

Timeline cronologica

  1. mercoledì 20 maggio 2026·biopharmadive.com

    Bristol Myers deepens AI investment with Anthropic deal

    The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many…

  2. mercoledì 20 maggio 2026·qz.com

    Bristol-Myers Squibb deploys Anthropic Claude to 30,000 employees

    The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs

1 mesi fa

Bristol Myers deploys Anthropic's Claude AI to accelerate drug discovery

Bristol Myers Squibb partners with Anthropic to deploy Claude AI across 30,000 employees, embedding agentic AI into drug discovery, clinical trials, and manufacturing.

Leggi questa versione → originale
pharmaceutical-technology.com1 mesi fa

BMS and Anthropic collaborate for Claude implementation

Bristol Myers Squibb (BMS) has signed a strategic agreement with Anthropic to implement its Claude platform across its global operations.

Leggi questa versione → originale
biopharmadive.com1 mesi fa

Bristol Myers deepens AI investment with Anthropic deal

The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many day-to-day activities.

Leggi questa versione → originale
fiercepharma.com1 mesi fa

BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,

Leggi questa versione → originale
  • mercoledì 20 maggio 2026·fiercepharma.com

    BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows

    Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,

  • giovedì 21 maggio 2026·cryptobriefing.com

    Bristol Myers deploys Anthropic's Claude AI to accelerate drug discovery

    Bristol Myers Squibb partners with Anthropic to deploy Claude AI across 30,000 employees, embedding agentic AI into drug discovery, clinical trials, and manufacturing.

  • giovedì 21 maggio 2026·pharmaceutical-technology.com

    BMS and Anthropic collaborate for Claude implementation

    Bristol Myers Squibb (BMS) has signed a strategic agreement with Anthropic to implement its Claude platform across its global operations.